Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To investigate safety and efficacy of varenicline tartrate in helping people quit smoking
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Varenicline tartrate | Drug | |||
| Placebo | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| To compare 12 weeks of treatment with varenicline 1 mg BID to placebo for smoking cessation, and to evaluate continuous abstinence from smoking for 12 weeks after the treatment period. |
| Measure | Description | Time Frame |
|---|---|---|
| To gather safety data for 12 weeks of treatment with varenicline 1 mg BID or placebo followed by 12 weeks of non-treatment follow-up. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Shenyang | Liaoning | 110016 | China | ||
| Pfizer Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37142273 | Derived | Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8. | |
| 19192221 | Derived | Wang C, Xiao D, Chan KP, Pothirat C, Garza D, Davies S. Varenicline for smoking cessation: a placebo-controlled, randomized study. Respirology. 2009 Apr;14(3):384-92. doi: 10.1111/j.1440-1843.2008.01476.x. Epub 2009 Feb 20. |
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Beijing |
| 100020 |
| China |
| Pfizer Investigational Site | Beijing | 100029 | China |
| Pfizer Investigational Site | Beijing | 100036 | China |
| Pfizer Investigational Site | Beijing | 100853 | China |
| Pfizer Investigational Site | Guangzhou | 510120 | China |
| Pfizer Investigational Site | Shanghai | 200233 | China |
| Pfizer Investigational Site | Shenyang | 110001 | China |
| Pfizer Investigational Site | Tanjin | 300052 | China |
| Pfizer Investigational Site | Singapore | 159964 | Singapore |
| Pfizer Investigational Site | Singapore | 169608 | Singapore |
| Pfizer Investigational Site | Singapore | 228310 | Singapore |
| Pfizer Investigational Site | Bangkok | 10330 | Thailand |
| Pfizer Investigational Site | Chiang Mai | 50200 | Thailand |
| ID | Term |
|---|---|
| D016540 | Smoking Cessation |
| ID | Term |
|---|---|
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D000068580 | Varenicline |
| ID | Term |
|---|---|
| D001552 | Benzazepines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D011810 | Quinoxalines |
Not provided
Not provided